These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6196450)

  • 1. Phase I study of human leukocyte interferon in patients with advanced cancer.
    Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA
    J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I evaluation of a synthetic mutant of beta-interferon.
    Hawkins M; Horning S; Konrad M; Anderson S; Sielaff K; Rosno S; Schiesel J; Davis T; DeMets D; Merigan T
    Cancer Res; 1985 Nov; 45(11 Pt 2):5914-20. PubMed ID: 4053062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of weekly high-dose human lymphoblastoid interferon.
    Connors JM; Silver HK
    Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients].
    Yoshimoto J; Tsushima T; Matsumura Y; Ohmori H; Saito N; Tanaka H; Asahi T; Ohkita K; Tanahashi T; Nanba K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomas.
    Edmonson JH; Long HJ; Frytak S; Smithson WA; Itri LM
    Cancer Treat Rep; 1987; 71(7-8):747-8. PubMed ID: 3038315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended phase I study of human beta-interferon in human cancer.
    Abdi EA; Kamitomo VJ; McPherson TA; Konrad MW; Inoue M; Tan YH
    Clin Invest Med; 1986; 9(1):33-40. PubMed ID: 3955919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G; Figlin R; McCarthy S
    J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA; Callaghan M; Sarna G
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of high-dose recombinant leukocyte alpha-2 interferon for metastatic colorectal cancer without previous systemic treatment.
    Eggermont AM; Weimar W; Marquet RL; Laméris JD; Jeekel J
    Cancer Treat Rep; 1985 Feb; 69(2):185-7. PubMed ID: 3882227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
    Krown SE; Burk MW; Kirkwood JM; Kerr D; Morton DL; Oettgen HF
    Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
    Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Laszlo J
    J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase-1 study of the tolerance for increasing doses of recombinant human alpha 2 interferon in patients with advanced cancer].
    Bretaudeau B; Palangie T; Giralt E; Jouve M; Pouillart P; Falcoff E; Fridman WH; Magdelenat H; Derstepani L; Laurent T
    Bull Cancer; 1984; 71(1):40-9. PubMed ID: 6713113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of rDNA human alpha-2 interferon in multiple myeloma.
    Wagstaff J; Loynds P; Scarffe JH
    Cancer Treat Rep; 1985 May; 69(5):495-8. PubMed ID: 4005872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancer.
    Sarna GP; Figlin RA
    Cancer Treat Rep; 1985 May; 69(5):547-9. PubMed ID: 4005877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W; Gastl G; Troppmair J; Tilg H; Abbrederis K; Nerl C; Flener R; Rokos H; Huber C
    Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
    Furue H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.